Navigation Links
Thorne Research and YouCare Pharmaceutical Group Announce Joint Venture Deal to Market Nutritional Supplements in China
Date:4/30/2013

SANDPOINT, Idaho, April 30, 2013 /PRNewswire/ -- Thorne Research, Inc., a leader in developing and manufacturing pure, high-quality nutritional supplements and personal care products, today announced that the company has entered a joint venture with YouCare Pharmaceutical Group Co. Ltd., a leading Chinese pharmaceutical company located in  Beijing.  Through this new joint venture, nutritional supplements and other natural health and personal care products manufactured by Thorne Research will be marketed and distributed throughout mainland China through YouCare's established sales and distribution networks.

"This strategic joint venture will allow Thorne to rapidly accelerate our global reach in one of the world's largest and fastest growing markets for nutritional supplements.  By combining the state-of-the-art research, development and manufacturing capabilities of Thorne Research with the extensive marketing resources and expertise of YouCare Pharmaceuticals, we are well positioned to become a leading lifestyle medicine company delivering high-quality, clinically proven nutraceutical products to markets throughout China in the years ahead," said Paul Jacobson , CEO of Thorne Research. 

In 2012, the market for nutraceuticals including traditional medicines in China was $90 billion USD, with an annual growth rate of 22%. It is expected that the market will be $140 billion USD within five years, which would make China the largest market for nutraceutical products in the world.  Through this strategic collaboration, Thorne will be able to access the Chinese market through YouCare's multiple sales and distribution channels. Under the joint venture agreement, Thorne will be responsible for manufacturing products in the United States and supporting marketing activities. Thorne's manufacturing platform has been designed to conform to the rigorous chemical manufacturing controls (CMC) of botanical drug specifications instituted by the US Food and Drug Administration (FDA) and is FDA 231CFR211 compliant. YouCare will provide expertise in all areas of product registration, marketing, commercialization and distribution. 

"YouCare Pharma has extensive experience in healthcare marketing and commercialization in China," said Weishi Yu , Executive Chairman of YouCare Pharma "We are ideally positioned to tap into the large and rapidly expanding demand for nutraceuticals in China. Factors including economic growth and an aging population are likely to increase demand for high quality nutritional supplements and lifestyle management products in China in the years ahead. As a leader in producing and marketing lifestyle solutions, Thorne is the ideal partner for YouCare to meet this demand and grow our business in this field.  Thorne's strict attention to quality in manufacturing and full Therapeutic Goods Administration (TGA) certification will be important advantages for us in this effort."

About Thorne Research, Inc.

Since 1984, Thorne Research has set the standard for exceptional quality manufacturing and formulation of premium hypoallergenic dietary supplements available through licensed health-care practitioners. With more than 400 products, Thorne Research is recognized by health-care practitioners as a leader in providing dietary supplements of the highest quality and purity. Through recent acquisitions and joint ventures, Thorne Research now also offers product lines that address the nutritional issues and requirements of those with cancer, cognitive and brain health, and cardiovascular health, in addition to a product line for high performance athletes, a comprehensive product line of organic, non-GMO skin-care products, and related supportive practice management programs. With locations in Sandpoint, ID and New York, NY, Thorne Research operates a state-of-the-art manufacturing facility and employs more than 250 people. Further information on Thorne Research is available at www.Thorne.com.

About YouCare Pharmaceutical Group Co., Ltd

YouCare Pharmaceutical Group was first founded in 1988 and registered in Beijing in 2001.The company currently has 16 subsidiary companies in China and one outside of China that are collectively engaged in R&D and product development including API, western medicine, TCMs, general health products, medical devices and contraceptives.   YouCare's business covers all phases of product development and distribution including R&D, production, inbound and outbound logistics, import/export and direct sales.

YouCare actively opens markets in pharmaceutical imports and exports and works to build cooperative ties with international pharmaceutical companies. The company has established relationships with many leading global companies in healthcare and has imported original research drug preparations and original API from Italy, France, Germany, Japan, Korea, India, Croatia and other regions.


'/>"/>
SOURCE Thorne Research, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The race toward an interferon free world: The current field of Hepatitis C Virus treatment research, including recent financial deals
2. Ludlow Research Issues Opinion on PMBS Based on Low Market Cap Valuation
3. Musculoskeletal Network covers the Osteoarthritis Research Society International Conference
4. Nephrology & Urology Devices Market is Expected to Reach USD 20.5 Billion Globally in 2018: Transparency Market Research
5. Express Scripts Research Shows Prescription Drug Utilization Declines for Payers of Workers Compensation
6. Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy Adds The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
7. X-Ray Market (Portable, Handheld, Digital Radiography, Computed Radiography, Flat Panel Detection Systems, Mammography) is Expected to Reach USD 9.8 Billion Globally in 2018: Transparency Market Research
8. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
9. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
10. Global Medical Robotic Systems Market is Expected to Reach USD 13.64 Billion by 2018: Transparency Market Research
11. Breast Pumps Market Is Expected to Reach USD 1.03 Billion Globally in 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 2016  The ALS Association, in partnership with ALS Finding ... generate a biomarker to track TDP43 aggregation. The successful team(s) ... $1 million investment. --> ... nerve cells in the brain and the spinal cord. Eventually, ... muscle movement, which often leads to total paralysis and death ...
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... CORAL SPRINGS, Florida , February 10, 2016 ... Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, ... Medivation, Inc. (NASDAQ: MDVN ), Adamas Pharmaceuticals, Inc. (NASDAQ: ... ). --> Today,s latest Orphan Drug Designations become ... granted by the FDA to novel drugs and biologics which ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... ... charity program created to assist the local community. Pledging to select a new ... nonprofit organizations in the area. Their goal is to bring community awareness to ...
(Date:2/10/2016)... ... ... 10 Best Water is excited to announce a new monthly ... topped the list as a result of their commitment to offering clients creative, customized, ... 5100, a top notch water company that specializes in providing the public with refreshing ...
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , ... in the North Metro Denver area. The new dental practice focuses on comfort where ... in the most relaxing environment. , While some dental visits can create anxiety for ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive ... than 200 of the country’s top healthcare executives to share insights on transformational ... of the Forum is the provider-centric perspective, experience, expertise and strategy shared by ...
(Date:2/10/2016)... ... February 10, 2016 , ... Gout is like no other joint pain. ... often severe, with intense swelling and redness. It is triggered by the crystallization of ... adults are the most susceptible, according to the February 2016 issue of Harvard Men's ...
Breaking Medicine News(10 mins):